LifeTech Scientific Corp (1302)

Currency in HKD
2.280
+0.080(+3.64%)
Closed·
1302 Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
1302 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1602.330
52 wk Range
1.2402.330
Key Statistics
Bid/Ask
2.28 / 2.28
Prev. Close
2.28
Open
2.23
Day's Range
2.16-2.33
52 wk Range
1.24-2.33
Volume
77.47M
Average Volume (3m)
41.87M
1-Year Change
44.74%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1302 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.621
Upside
+14.97%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

LifeTech Scientific Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

LifeTech Scientific Corp Company Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

Compare 1302 to Peers and Sector

Metrics to compare
1302
Peers
Sector
Relationship
P/E Ratio
43.7x−27.2x−0.6x
PEG Ratio
−3.140.030.00
Price/Book
2.8x2.5x2.6x
Price / LTM Sales
7.5x6.6x3.3x
Upside (Analyst Target)
15.1%−5.3%39.1%
Fair Value Upside
Unlock−12.0%4.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.621
(+14.97% Upside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
650.87M / --
EPS Revisions
Last 90 days

1302 Income Statement

FAQ

What Stock Exchange Does LifeTech Scientific Corp Trade On?

LifeTech Scientific Corp is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for LifeTech Scientific Corp?

The stock symbol for LifeTech Scientific Corp is "1302."

What Is the LifeTech Scientific Corp Market Cap?

As of today, LifeTech Scientific Corp market cap is 10.51B.

What Is LifeTech Scientific Corp's Earnings Per Share (TTM)?

The LifeTech Scientific Corp EPS (TTM) is 0.05.

From a Technical Analysis Perspective, Is 1302 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has LifeTech Scientific Corp Stock Split?

LifeTech Scientific Corp has split 1 times.

How Many Employees Does LifeTech Scientific Corp Have?

LifeTech Scientific Corp has 1395 employees.

What is the current trading status of LifeTech Scientific Corp (1302)?

As of 19 Aug 2025, LifeTech Scientific Corp (1302) is trading at a price of 2.28, with a previous close of 2.28. The stock has fluctuated within a day range of 2.16 to 2.33, while its 52-week range spans from 1.24 to 2.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.